Research - Hamburg, Hamburg, Germany
GLYCONIC developed a unique biotechnological platform to selectively rhamnosylate natural compounds. The technology enables the efficient production of new rhamnosides, e.g. as active ingredients for cosmeceutical and nutraceutical applications.